0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover755.28%IV-244.83%PremiumJul 19, 2024Expiry Date3.55Intrinsic Value100Multiplier10DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.6402Delta0.2064Gamma0.38Leverage Ratio-0.0336Theta-0.0010Rho-0.24Eff Leverage0.0009Vega
Milestone Pharmaceuticals Stock Discussion
Milestone Pharmaceuticals Announces FDA Acceptance of New Drug Application for CARDAMYST™
Milestone Pharmaceuticals announced the FDA's acceptance of its New Drug Application for CARDAMYST, an etripamil nasal spray intended for managing paroxysmal supraventricular tachycardia (PSVT). This milestone occurred on May 26, 2024, with a Prescription Drug User Fee Act (PDUFA) target date set for ten months later. The clinical trial program for CARDAMYST is the l...
NEWS
Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024
S&P 500 Approaches All-Time High
US stocks rose, with the $S&P 500 Index(.SPX.US)$ approaching its all-time, high as optimism over potential interest rate cuts next year continued to fuel positive sentiment on the last trading week of the year.
The S&P 500 closed 0.42% higher at 4,774.75 on the first day of the holiday-shortened trading week. The $Nasdaq Composite Index(.IXIC.US)$ gained 0.5% to 15,074.57, while the $Dow Jones Industrial Average(.DJI.US)$ added 0.4...
$Lemonade(LMND.US)$ initiated at underweight by Morgan Stanley, announced targe price at $14.00.
$Baidu(BIDU.US)$ was upgraded by Morgan Stanley from equal-weight to overweight, increased target price from $160.00 to $190.00.
$Philip Morris International(PM.US)$ was upgraded by Citigroup from neutral to buy, increased target price from $10...
Top Medical News of the Week
Lab-grown blood given to humans in world-first trial aimed at combatting rare disorders
Blood grown in a laboratory has been transfused into humans for the first time in a landmark clinical trial that U.K. researchers say could significantly improve treatment for people with blood disorders and r...
• $Innoviz Technologies(INVZ.US)$ +18.7% (selected by "large automotive group manufacturer" to become its direct LiDAR supplier across multiple brands)
• $Hilltop Holdings(HTH.US)$ +15.7% (commenced a modified "Dutch auction" tender offer to purchase for cash up to $400 mln of its common stock at a price per share not less than $28,00 and not greater than $32.00 less any applicable withholding taxes and without interest usin...
No comment yet